These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 11252025

  • 1. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
    Joyce JN.
    Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
    [Abstract] [Full Text] [Related]

  • 2. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors.
    Robertson GS, Lee CJ, Sridhar K, Nakabeppu Y, Cheng M, Wang YM, Caron MG.
    Eur J Neurosci; 2004 Dec; 20(11):3189-94. PubMed ID: 15579174
    [Abstract] [Full Text] [Related]

  • 3. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA, Mansour A, Watson SJ.
    Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758
    [Abstract] [Full Text] [Related]

  • 4. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 5. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G, Zhou LW, Morabito M, Zhang SP, Weiss B.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [Abstract] [Full Text] [Related]

  • 6. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL, Schaus JM, Gehlert DR.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [Abstract] [Full Text] [Related]

  • 7. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J, Makkai B, Gulyás B, Hall H.
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [Abstract] [Full Text] [Related]

  • 8. Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja.
    Gurevich EV, Himes JW, Joyce JN.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):587-98. PubMed ID: 10087054
    [Abstract] [Full Text] [Related]

  • 9. Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
    Andersson M, Terasmaa A, Fuxe K, Strömberg I.
    J Neurosci Res; 2005 Oct 15; 82(2):264-72. PubMed ID: 16175569
    [Abstract] [Full Text] [Related]

  • 10. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
    Huang XF, Tan YY, Huang X, Wang Q.
    Neurosci Res; 2007 Nov 15; 59(3):314-21. PubMed ID: 17868938
    [Abstract] [Full Text] [Related]

  • 11. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.
    Addict Biol; 2009 Jul 15; 14(3):283-93. PubMed ID: 19298320
    [Abstract] [Full Text] [Related]

  • 12. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS.
    Neuropeptides; 2005 Oct 15; 39(5):515-23. PubMed ID: 16154634
    [Abstract] [Full Text] [Related]

  • 13. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
    Levant B, Grigoriadis DE, DeSouza EB.
    J Pharmacol Exp Ther; 1993 Feb 15; 264(2):991-1001. PubMed ID: 8437136
    [Abstract] [Full Text] [Related]

  • 14. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment.
    Joyce JN, Der TC, Renish L, Osredkar T, Hagner D, Reploge M, Sakakibara S, Ueda S.
    Exp Neurol; 2004 May 15; 187(1):178-89. PubMed ID: 15081599
    [Abstract] [Full Text] [Related]

  • 15. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.
    Egan MF, Hurd Y, Hyde TM, Weinberger DR, Wyatt RJ, Kleinman JE.
    Synapse; 1994 Nov 15; 18(3):178-89. PubMed ID: 7531873
    [Abstract] [Full Text] [Related]

  • 16. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C, Toska K, Friberg L, Holm S, Angelo HR, Knudsen GM.
    J Cereb Blood Flow Metab; 2001 Jan 15; 21(1):92-7. PubMed ID: 11149673
    [Abstract] [Full Text] [Related]

  • 17. Effects of long-term treatment of haloperidol on D2 dopamine receptors in various areas of rat brain.
    Watanabe M, Ohtakeno S, Watanabe H, Mamiya G, Ichinowatari N.
    Yakubutsu Seishin Kodo; 1993 Oct 15; 13(5):315-9. PubMed ID: 8266741
    [Abstract] [Full Text] [Related]

  • 18. Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals.
    Stanwood GD, Artymyshyn RP, Kung MP, Kung HF, Lucki I, McGonigle P.
    J Pharmacol Exp Ther; 2000 Dec 15; 295(3):1223-31. PubMed ID: 11082459
    [Abstract] [Full Text] [Related]

  • 19. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
    Burris KD, Filtz TM, Chumpradit S, Kung MP, Foulon C, Hensler JG, Kung HF, Molinoff PB.
    J Pharmacol Exp Ther; 1994 Feb 15; 268(2):935-42. PubMed ID: 8114008
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS, Yablonsky-Alter E, Lidsky TI, Banerjee SP.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):181-6. PubMed ID: 18457824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.